Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and ultimately respiratory failure. The disease is often fatal within 3 to 5 years of diagnosis. Though the prevalence of amyotrophic lateral sclerosis is relatively low, with approximately 2 per 100,000 people affected annually, it continues to pose...

  The trastuzumab biosimilar market has emerged as a significant segment within the global biopharmaceutical industry. Trastuzumab, originally marketed under the brand name Herceptin by Roche, is an essential treatment for HER2-positive breast cancer and gastric cancer. As patents for the drug expired, biosimilars—medications that are highly similar but not identical to the reference...